Related Experiment Video
Updated: May 24, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Neuropsychiatric systemic lupus erythematosus
1Department of Neurology, Epilepsy Division, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Current Neuropharmacology
|March 2, 2012
Summary
Neuropsychiatric systemic lupus erythematosus (NPSLE) involves complex brain injury mechanisms. Current treatments are varied, with new therapies like Belimumab showing promise for managing these challenging lupus manifestations.
Area of Science:
- Immunology
- Neurology
- Rheumatology
Background:
- Neuropsychiatric systemic lupus erythematosus (NPSLE) is a complex and prevalent manifestation of lupus.
- Its pathogenesis involves multifactorial processes including cytokines, autoantibodies, and immune complexes leading to neuronal injury.
Purpose of the Study:
- To review the pathophysiology of NPSLE.
- To discuss current and emerging treatment strategies for NPSLE.
Main Methods:
- Literature review focusing on NPSLE pathogenesis and treatment.
- Analysis of various therapeutic approaches, including conventional and novel agents.
Main Results:
- NPSLE pathogenesis is multifactorial, involving inflammatory and immune-mediated neuronal damage.
- Current management is multimodal, encompassing anti-inflammatories, immunosuppressants, and symptomatic treatments.
- Advanced therapies like IVIG, plasmapheresis, rituximab, and biological agents (e.g., Belimumab) are used for refractory cases.
Conclusions:
- Understanding NPSLE pathophysiology is crucial for effective management.
- Multimodal and personalized treatment approaches are essential.
- Emerging biological therapies offer new hope for patients with refractory NPSLE.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...